
Nate O'Connell, PhD
@nateoconnellphd
PhD Biostatistician; Assistant Prof @WakeBDS @wakeforestmed & @WakeCancer; clinical trials, Bayesian stats, prediction models, applied stats; Views are my own
ID: 164796637
09-07-2010 19:48:35
92 Tweet
182 Takipçi
387 Takip Edilen

What are the #mechanisms for #migraine relief from #mindfulness? Hot off the press, excited to share our findings after years of analysis and work Wake Forest University School of Medicine Atrium Health Wake Forest Baptist American Headache Society American Academy of Neurology Paige Estave, MD, PhD Nate O'Connell, PhD Elizabeth Seng NIH NCCIH 2022 International Congress Women Neurologists Group

15k patients wireless wearable hemodynamic monitoring outside ICU Atrium Health Wake Forest Baptist q15 seconds MAP,SBP,HR with linked alarms. Hemodynamic disturbances common on hospital wards-majority are missed without continuous monitoring. ASA® APSF Society of Critical Care Anesthesiologists SCCM ASER


Ken Tegtmeyer, MD, FCCM, FAAP 🇺🇸 🟧 Raw numbers suggest a relationship with clinical deterioration. Still working to finalize the results of clinicaltrials.gov/ct2/show/NCT04… Nate O'Connell, PhD Alarm fatigue needs a deeper understanding of the human element of response to monitoring alerts!


I’m excited to share our paper just published today by Journal of Clinical Oncology: “Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial” ascopubs.org/doi/10.1200/JC…





Our article is officially published highlighting the potential of physical activity to preserve cardiovascular health during cancer treatment ♥️ TONS of awesome teamwork in this pub. VCU Health Pauley Heart Center VCU Massey Comprehensive Cancer Center Wake Forest University School of Medicine

🧐 Grade 1 and 2 AEs are associated w/ increased odds of patient side effect burden & treatment dropout: brnw.ch/21wEtQp #QOL Nate O'Connell, PhD


Insightful commentary in this editorial on the collection of low-moderate AEs in response to our original paper in Journal of Clinical Oncology - Patient Experience, Adverse Event Reporting, and Clinical Trial Design | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…



Excited to share coverage by Oncology Times of our work on the importance of low-grade AEs and their impact on treatment discontinuation and patient side-effect burden from the ECOG-ACRIN Cancer Research Group trial E1912 published in Journal of Clinical Oncology! See here: journals.lww.com/oncology-times… Lynne I Wagner PhD



Excited to share our newly published paper “A comparison of random forest variable selection methods for regression modeling of continuous outcomes” with Jaime Lynn Speiser Garrett Bullock PT, DPT, DPhil and Byron Jaeger academic.oup.com/bib/article/26…